Amylin Pharmaceuticals, Inc. Board Battle Heats Up with Proxy Filing
BOSTON, April 3 (Reuters) - Eastbourne Capital Management filed preliminary proxy materials on Friday in its battle to elect five nominees to the board of Amylin Pharmaceuticals Inc (AMLN.O), which makes the diabetes drug Byetta.